Pharmazz, Inc.

This study tests a new drug called LYFAQUIN (centhaquine) for people in hypovolemic shock, a life-threatening condition from severe blood or fluid loss. The drug aims to raise blood pressure and improve blood flow to help the body recover. About 400 adults in the emergency room o…

This study tests a drug called sovateltide for newborns with hypoxic-ischemic encephalopathy (HIE), a serious brain injury from lack of oxygen at birth. The drug aims to help the brain repair itself and reduce the risk of death or long-term disability. About 40 full-term babies w…

This study tests a new drug called sovateltide for people who have had a stroke caused by a blood clot in the brain. The goal is to see if it helps patients recover better and have less disability. About 514 adults aged 18 to 80 will receive the drug or a placebo alongside standa…

This study tests a drug called sovateltide in people who have had a stroke caused by a blood clot in the brain. The goal is to see if it is safe and helps improve recovery. About 160 adults aged 18 to 78 will receive the drug or a placebo within 24 hours of their stroke. Research…